Graham Lowe
Direttore/Membro del Consiglio presso Deltex Medical Ltd.
Posizioni attive di Graham Lowe
Società | Posizione | Inizio | Fine |
---|---|---|---|
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Direttore/Membro del Consiglio | 01/11/2004 | - |
Storia della carriera di Graham Lowe
Precedenti posizioni note di Graham Lowe
Società | Posizione | Inizio | Fine |
---|---|---|---|
DELTEX MEDICAL GROUP PLC | Direttore operativo | 01/01/2002 | - |
Vendite & Marketing | 01/01/2002 | 01/01/2016 |
Statistiche
Distribuzione geografica
Regno Unito | 3 |
Posizioni
Chief Operating Officer | 1 |
Sales & Marketing | 1 |
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
DELTEX MEDICAL GROUP PLC | Health Technology |
Aziende private | 1 |
---|---|
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Distribution Services |
- Borsa valori
- Insiders
- Graham Lowe
- Esperienza